Logo image
Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres
Journal article   Open access   Peer reviewed

Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres

Natalie Commins, Deloshaan Subhaharan, Rajiv Kurup, Tehara Wickremeratne, Jonathan Mitchell, Julie Elmes, Alicia Braund, Natalie Funakoshi, Jonathan Langton, Paul Leschke, …
Internal Medicine Journal, Vol.54(8), pp.1302-1309
2024
PMID: 38654627
pdf
Internal Medicine Journal - 2024 - Commins - Indications and outcomes of transjugular intrahepatic portosystemic shunt690.38 kBDownloadView
Published VersionCC BY-NC-ND V4.0 Open Access

Abstract

liver cirrhosis portal hypertension end stage liver disease hepatology interventional radiology
Background Transjugular intrahepatic portosystemic shunt (TIPS) is an important therapy for complications of portal hypertension but remains underutilised in regional settings. Aims The aim of this study is to explore the demographics, indications, outcomes and complications in patients undergoing TIPS in two regional hepatology centres. Methods Retrospective analysis was undertaken of all patients undergoing TIPS at two regional centres between January 2017 and March 2023. The primary outcome measures were efficacy and complications of TIPS. Patient demographics (such as age, baseline liver severity scores and aetiology of liver disease) and indications for TIPS are detailed. Results Forty-eight patients underwent TIPS. Median age was 56 years (interquartile range (IQR): 46–65). The most common indications for TIPS were refractory ascites (n = 17) and failure of secondary prophylaxis of variceal bleeding (n = 13). Cumulative survival at 3 months and 1 year was 93% and 77% respectively. There was no significant difference in outcomes based on TIPS indication. The median number of paracenteses in patients undergoing TIPS for refractory ascites 1 year pre- and post-TIPS were 10 (IQR: 4.5–16) and 2 (IQR: 0–4) respectively (P < 0.001). There were no procedure-related deaths. Inpatient management of liver disease complications had a mean cost of $32 874.67 (SEM: 7779) in 1 year pre-TIPS compared with $12 304.70 (SEM: 3531.1) in 1 year post-TIPS (P < 0.001). Conclusions TIPS is a safe and effective treatment to reduce complications of portal hypertension and can be performed successfully in the regional setting.

Details

Metrics

7 File views/ downloads
73 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Gastroenterology & Hepatology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image